Additionally, TPX2 overproduction enhanced the TCF/LEF transcriptional activity, while the introduction of a Wnt/β-catenin pathway inhibitor partly mitigated the GC advancement enhanced by overproducing TPX2. The gene discussed is HNF4A; the disease is gastric cancer.